S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN-LABEL, KEYNOTE-667 STUDY

S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN-LABEL, KEYNOTE-667 STUDY

Bibliographic Details
Main Authors: L. Vinti, S. Daw, C. Sabado Alvarez, F. Fagioli, A. Beishuizen, G. Michel, M. L. Moleti, M. Cepelova, A. Thorwarth, C. Rigaud, D. Plaza Lopez de Sabando, J. Landman Parker, Y. Zhu, P. Pillai, A. Nahar, C. Mauz-Koerholz
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000843708.43092.96

Similar Items

Similar Items